Valuation: DMS

Market Cap 23.48M 26.22M 21.6M 19.57M 36.59M 2.49B 37.27M 258M 103M 1.31B 98.41M 96.31M 4.13B P/E 2026 *
45.4x
P/E 2027 * 10.1x
Enterprise Value 41.88M 46.77M 38.53M 34.91M 65.25M 4.44B 66.47M 459M 184M 2.34B 176M 172M 7.37B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.57x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-17
Director of Finance/CFO - 2021-12-31
Chief Tech/Sci/R&D Officer - 2018-12-31
Director TitleAgeSince
Chairman 53 2022-07-17
Director/Board Member 52 2025-06-15
Director/Board Member - 2023-07-23
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 27.03M
-1.72%+3.44%+25.31%+60.56% 262B
-2.00%+0.75%+7.99%+25.46% 167B
-3.73%-4.48%-18.49%+67.13% 156B
-1.66%-8.12%-58.26%-16.12% 61.87B
-2.57%+3.30%+10.22%+47.55% 54.44B
0.00%+2.46%-11.97%-6.29% 53.3B
-3.47%+1.04%+21.98%+72.85% 51.07B
+0.84%-3.12%+9.80%+64.47% 50.25B
-3.61%+1.99%+34.94%+95.49% 47.17B
Average -1.79%-0.30%+2.39%+45.68% 100.29B
Weighted average by Cap. -2.12%+0.14%+5.17%+47.96%

Financials

2026 *2027 *
Net sales 44.9M 50.13M 41.3M 37.42M 69.95M 4.76B 71.26M 493M 198M 2.5B 188M 184M 7.9B 60M 66.99M 55.19M 50.01M 93.48M 6.36B 95.23M 658M 264M 3.35B 251M 246M 10.55B
Net income 400K 447K 368K 333K 623K 42.41M 635K 4.39M 1.76M 22.31M 1.68M 1.64M 70.35M 2.3M 2.57M 2.12M 1.92M 3.58M 244M 3.65M 25.23M 10.13M 128M 9.64M 9.43M 405M
Net Debt 18.4M 20.54M 16.93M 15.34M 28.67M 1.95B 29.2M 202M 81.02M 1.03B 77.1M 75.46M 3.24B 10.9M 12.17M 10.03M 9.08M 16.98M 1.16B 17.3M 120M 48M 608M 45.68M 44.7M 1.92B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DMS